Trial
NCT05419479
Switch Maintenance in Pancreatic
Phase ISUSPENDEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
James Cleary, MD, PhD
Collaborators
Arcus Biosciences, Inc.; Lustgarten Foundation
Condition
Pancreatic Cancer
Intervention
ZIMBERELIMAB
Why stopped
Efficacy concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04